TFX

01/01/1985 - "TFX in vivo appears to restore immunocompetence, decrease infections, and prolong remissions in children with ALL in remission."
12/01/2023 - "Comparing unilateral RoboTFX versus open TFX, neither fracture healing rate, infection rate, Majeed pelvic outcome score, Mears' radiological evaluation criterion, nor Gibbons score of the two groups were statistically significantly different (p > 0.05). "
01/01/2010 - "Treatment with TFX increased the proportion of apoptotic lymphocytes and decreased the proportion of necrotic lymphocytes from 14 to 60 days after infection in mice infected with T. "
01/01/2002 - "Furthermore, administration of TFX prior to infection also potentiates the stimulatory effect of T. "
01/01/2002 - "Pretreatment with TFX does not change the inhibitory effect of infection on the percentage of CD8+ splenocytes, but potentiates the percentage of CD4+ spleen cells and mesenteric lymphonode cells increased by infection. "

07/23/1989 - "The authors conclude that TFX may be helpful in the treatment of the autoimmunological diseases, including the systemic lupus erythematosus."
07/23/1989 - "[Possibility of using TFX (thymus factor X) in the treatment of systemic lupus erythematosus]."

01/01/1995 - "Interferon (IFN) induction in leukocytes of cows with fatty liver, elevated ketone bodies, free fatty acids, bilirubin concentration and high aspartate aminotransferase (AST) activity, revealed impaired IFN production which was not improved by using known immunomodulators such as isoprinosine, levamisole, TFX and lactoferrin. "

01/01/1994 - "TFX-thumomodulin could be effective in reducing the changes of examined surface markers, caused by radiotherapy in breast cancer patients."
01/01/1994 - "A quantification of peripheral blood CD2, CD3, CD4, CD8 i CDDR positive cells was performed to evaluate effectiveness of a bovine thymic extract, TFX-thymomodulin in expresing those surface markers, modulated by postoperative radiotherapy in breast cancer patients. "
01/01/1994 - "Twenty patients with histologically proven breast cancer, assigned to clinical stage II using the criteria of TNM (Tumour Node Metastasis) classification were divided into two compatative groups: the first one was treated with radiotherapy only, whereas the second one was additionally treated with TFX-thymomodulin. "

01/01/1976 - "A trial of immunologic stimulation with thymic extract (TFX) in untreated chronic lymphocytic leukemia."